Ola Landgren, MD, PhD
Multiple Myeloma Cancer Chair
Chief, Myeloma Program
Leader, Experimental Therapeutics Program
Sylvester Comprehensive Cancer Center
Professor of Medicine
University of Miami
Miami, FL
Hematologic oncologist, Ola Landgren, MD, PhD, was recently appointed the inaugural leader of a new research program, Experimental Therapeutics, at Sylvester Comprehensive Cancer Center at the University of Miami Health System and the Miller School of Medicine. Landgren completed his medical degree and doctorate at Karolinska Institute in Stockholm, Sweden. He is board certified in hematology and internal medicine. As part of his ongoing research program, Landgren is studying molecular mechanisms underlying the trajectory from precursor to full-blown multiple myeloma with the goal to develop treatment strategies aiming to delay, prevent, and ultimately define a cure for multiple myeloma.
